- Home
- TCBP vs HSDT Comparison
TCBP vs HSDT Comparison
Compare TCBP & HSDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TCBP
- HSDT
- Stock Information
- Founded
- TCBP 2013
- HSDT 2014
- Country
- TCBP United Kingdom
- HSDT United States
- Employees
- TCBP N/A
- HSDT N/A
- Industry
- TCBP Biotechnology: Biological Products (No Diagnostic Substances)
- HSDT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TCBP Health Care
- HSDT Health Care
- Exchange
- TCBP Nasdaq
- HSDT Nasdaq
- Market Cap
- TCBP 3.0M
- HSDT 2.5M
- IPO Year
- TCBP 2022
- HSDT N/A
- Fundamental
- Price
- TCBP $0.65
- HSDT $0.49
- Analyst Decision
- TCBP Strong Buy
- HSDT Buy
- Analyst Count
- TCBP 1
- HSDT 2
- Target Price
- TCBP $3.00
- HSDT $24.00
- AVG Volume (30 Days)
- TCBP 814.6K
- HSDT 236.6K
- Earning Date
- TCBP 02-09-2025
- HSDT 11-12-2024
- Dividend Yield
- TCBP N/A
- HSDT N/A
- EPS Growth
- TCBP N/A
- HSDT N/A
- EPS
- TCBP N/A
- HSDT N/A
- Revenue
- TCBP N/A
- HSDT $502,000.00
- Revenue This Year
- TCBP N/A
- HSDT N/A
- Revenue Next Year
- TCBP N/A
- HSDT $8.97
- P/E Ratio
- TCBP N/A
- HSDT N/A
- Revenue Growth
- TCBP N/A
- HSDT N/A
- 52 Week Low
- TCBP $0.44
- HSDT $0.37
- 52 Week High
- TCBP $41.50
- HSDT $9.50
- Technical
- Relative Strength Index (RSI)
- TCBP 36.84
- HSDT 44.03
- Support Level
- TCBP $0.45
- HSDT $0.43
- Resistance Level
- TCBP $0.70
- HSDT $0.76
- Average True Range (ATR)
- TCBP 0.08
- HSDT 0.08
- MACD
- TCBP 0.10
- HSDT -0.01
- Stochastic Oscillator
- TCBP 55.58
- HSDT 17.91
About TCBP TC BioPharm (Holdings) plc
TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.
About HSDT Helius Medical Technologies Inc. (DE)
Helius Medical Technologies Inc is a neurotech company focused on neurological wellness. The company's purpose is to develop, license, or acquire non-invasive technologies targeted at reducing symptoms of neurological disease or trauma. The company's product, known as the Portable Neuromodulation Stimulator (PoNS), is authorized for sale in Canada as a class II, a non-implantable medical device intended for use as a short-term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury and is to be used in conjunction with supervised therapeutic exercise.